Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$17,868,313
+$474,941 QoQ
Shares Held
70,356
-1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.46%
of 13F equity value
Holder Rank
#792
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INDEPENDENT INVESTORS INC holds $43,440,882 across 7 Drug Manufacturers - General names. JNJ ranks #1 (41.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
70,356 | $17,868,313 | |
| 2 | AMGN |
Amgen Inc
|
29,176 | $10,565,213 | |
| 3 | ABBV |
AbbVie Inc.
|
40,274 | $10,134,549 | |
| 4 | NVS |
Novartis AG
|
17,900 | $2,805,288 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
25,438 | $1,465,737 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,500 | $321,250 | |
| 7 | PFE |
Pfizer Inc
|
11,650 | $280,532 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,868,313 | 70,356 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $17,393,372 | 71,156 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $14,807,686 | 71,552 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $13,267,171 | 71,552 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $10,963,020 | 71,771 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $11,902,502 | 71,771 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $10,386,753 | 71,821 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $11,639,311 | 71,821 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $10,497,357 | 71,821 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $11,361,363 | 71,821 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $11,321,643 | 72,232 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $11,250,134 | 72,232 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $12,764,074 | 77,115 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $11,952,825 | 77,115 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $13,622,364 | 77,115 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $12,695,522 | 77,715 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $13,795,189 | 77,715 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $13,773,429 | 77,715 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $13,294,705 | 77,715 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $12,631,722 | 78,215 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $13,091,064 | 79,465 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $13,084,725 | 79,615 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $12,561,284 | 79,815 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $12,061,513 | 81,015 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $11,393,280 | 81,016 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $10,623,628 | 81,016 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||